US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist

16.8300
0.00000.00%

Trading Nov 27 16:00 ET

22.22MMarket Cap-1389P/E (TTM)

Pieris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

101.50%146K

88.98%-1.48M

36.38%-7M

10.20%-53.82M

-52.08%-19.67M

-10.77%-9.72M

13.78%-13.43M

51.44%-11M

-682.40%-59.93M

-18.17%-12.93M

Net income from continuing operations

73.15%-2.89M

-190.29%-3.59M

62.89%-4.89M

26.25%-24.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

27.24%-33.28M

15.00%-8.1M

Operating gains losses

---6K

----

85.90%-53K

--0

---106K

--53K

---376K

---77K

Depreciation and amortization

--0

-105.25%-30K

-35.94%1.78M

-138.12%-223K

-8.29%708K

24.36%725K

-32.02%571K

17.40%2.78M

-0.51%585K

Other non cash items

4,568.42%849K

-56.04%-284K

1,868.06%1.42M

-36.26%-124K

101.63%5K

-1,050.00%-19K

-247.97%-182K

-20.88%72K

-203.33%-91K

-448.21%-307K

Change In working capital

111.99%1.86M

111.60%2.19M

-752.88%-3.96M

-44.26%-48.14M

-139.71%-14.34M

-3,341.02%-15.52M

-159.26%-18.89M

103.09%607K

-209.32%-33.37M

-83.24%-5.98M

-Change in receivables

----

302.25%5.31M

----

-44.73%-2.62M

----

-Change in prepaid assets

----

174.96%1.02M

----

56.94%-1.36M

----

-Change in payables and accrued expense

----

61.95%-3.13M

----

-148.53%-8.21M

----

-Change in other current liabilities

----

-1,048.89%-11.37M

----

-0.20%-990K

----

-Change in other working capital

----

-98.00%-39.97M

----

-203.22%-20.19M

----

Cash from discontinued investing activities

Operating cash flow

101.50%146K

88.98%-1.48M

36.38%-7M

10.20%-53.82M

-52.08%-19.67M

-10.77%-9.72M

13.78%-13.43M

51.44%-11M

-682.40%-59.93M

-18.17%-12.93M

Investing cash flow

Cash flow from continuing investing activities

107.16%142K

259.30%2.18M

-24.39%9M

156.52%12M

211.56%3.45M

-136.27%-1.98M

87.43%-1.37M

170.23%11.9M

-2,137.72%-21.24M

423.68%1.11M

Net PPE purchase and sale

3,459.42%2.32M

--0

83.57%-171K

18.18%13K

-102.94%-69K

89.35%-67K

87.66%-48K

-9.69%-1.04M

103.22%11K

Net investment purchase and sale

-13.63%-2.18M

267.51%2.18M

-24.69%9M

160.28%12.17M

213.50%3.44M

-134.79%-1.92M

87.31%-1.3M

172.17%11.95M

---20.2M

--1.1M

Cash from discontinued investing activities

Investing cash flow

107.16%142K

259.30%2.18M

-24.39%9M

156.52%12M

211.56%3.45M

-136.27%-1.98M

87.43%-1.37M

170.23%11.9M

-2,137.72%-21.24M

423.68%1.11M

Financing cash flow

Cash flow from continuing financing activities

174.40%19.8M

-84.95%14K

-87.80%7.21M

-98.10%93K

Net common stock issuance

--0

----

185.02%19.73M

--0

----

-87.88%6.92M

--0

Proceeds from stock option exercised by employees

--0

----

-77.40%66K

-84.95%14K

--0

----

-85.59%292K

-60.43%93K

Cash from discontinued financing activities

Financing cash flow

--0

----

174.40%19.8M

-84.95%14K

--0

----

-87.80%7.21M

-98.10%93K

Net cash flow

Beginning cash position

-56.09%19.73M

-51.98%19.08M

-54.97%17.4M

-67.19%38.64M

-32.07%32.89M

-17.18%44.94M

-52.54%39.74M

-67.19%38.64M

67.19%117.76M

-61.28%48.42M

Current changes in cash

102.46%288K

-86.04%696K

120.95%2M

70.22%-22.02M

-38.12%-16.21M

-286.88%-11.71M

119.05%4.98M

102.75%907K

-246.39%-73.95M

-83.76%-11.73M

Effect of exchange rate changes

-94.66%-656K

-123.11%-49K

-258.00%-316K

115.13%783K

-63.60%708K

88.00%-337K

106.39%212K

120.12%200K

-62.23%-5.18M

315.39%1.95M

End cash Position

-41.14%19.36M

-56.09%19.73M

-51.98%19.08M

-54.97%17.4M

-32.07%32.89M

-17.18%44.94M

-52.54%39.74M

-67.19%38.64M

Free cash flow

101.49%146K

89.04%-1.48M

36.65%-7M

11.45%-53.99M

-52.11%-19.66M

-11.12%-9.79M

16.71%-13.5M

52.05%-11.04M

-608.25%-60.97M

-14.50%-12.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	101.50%146K	88.98%-1.48M	36.38%-7M	10.20%-53.82M	-52.08%-19.67M	-10.77%-9.72M	13.78%-13.43M	51.44%-11M	-682.40%-59.93M	-18.17%-12.93M
Net income from continuing operations	73.15%-2.89M	-190.29%-3.59M	62.89%-4.89M	26.25%-24.54M	43.42%-4.58M	-10.44%-10.75M	138.46%3.98M	-158.44%-13.18M	27.24%-33.28M	15.00%-8.1M
Operating gains losses	---6K	----	----	85.90%-53K	--0	--0	---106K	--53K	---376K	---77K
Depreciation and amortization	--0	--0	-105.25%-30K	-35.94%1.78M	-138.12%-223K	-8.29%708K	24.36%725K	-32.02%571K	17.40%2.78M	-0.51%585K
Other non cash items	4,568.42%849K	-56.04%-284K	1,868.06%1.42M	-36.26%-124K	101.63%5K	-1,050.00%-19K	-247.97%-182K	-20.88%72K	-203.33%-91K	-448.21%-307K
Change In working capital	111.99%1.86M	111.60%2.19M	-752.88%-3.96M	-44.26%-48.14M	-139.71%-14.34M	-3,341.02%-15.52M	-159.26%-18.89M	103.09%607K	-209.32%-33.37M	-83.24%-5.98M
-Change in receivables	----	----	----	302.25%5.31M	----	----	----	----	-44.73%-2.62M	----
-Change in prepaid assets	----	----	----	174.96%1.02M	----	----	----	----	56.94%-1.36M	----
-Change in payables and accrued expense	----	----	----	61.95%-3.13M	----	----	----	----	-148.53%-8.21M	----
-Change in other current liabilities	----	----	----	-1,048.89%-11.37M	----	----	----	----	-0.20%-990K	----
-Change in other working capital	----	----	----	-98.00%-39.97M	----	----	----	----	-203.22%-20.19M	----
Cash from discontinued investing activities
Operating cash flow	101.50%146K	88.98%-1.48M	36.38%-7M	10.20%-53.82M	-52.08%-19.67M	-10.77%-9.72M	13.78%-13.43M	51.44%-11M	-682.40%-59.93M	-18.17%-12.93M
Investing cash flow
Cash flow from continuing investing activities	107.16%142K	259.30%2.18M	-24.39%9M	156.52%12M	211.56%3.45M	-136.27%-1.98M	87.43%-1.37M	170.23%11.9M	-2,137.72%-21.24M	423.68%1.11M
Net PPE purchase and sale	3,459.42%2.32M	--0	--0	83.57%-171K	18.18%13K	-102.94%-69K	89.35%-67K	87.66%-48K	-9.69%-1.04M	103.22%11K
Net investment purchase and sale	-13.63%-2.18M	267.51%2.18M	-24.69%9M	160.28%12.17M	213.50%3.44M	-134.79%-1.92M	87.31%-1.3M	172.17%11.95M	---20.2M	--1.1M
Cash from discontinued investing activities
Investing cash flow	107.16%142K	259.30%2.18M	-24.39%9M	156.52%12M	211.56%3.45M	-136.27%-1.98M	87.43%-1.37M	170.23%11.9M	-2,137.72%-21.24M	423.68%1.11M
Financing cash flow
Cash flow from continuing financing activities	0			174.40%19.8M	-84.95%14K	0			-87.80%7.21M	-98.10%93K
Net common stock issuance	--0	----	----	185.02%19.73M	--0	--0	----	----	-87.88%6.92M	--0
Proceeds from stock option exercised by employees	--0	----	----	-77.40%66K	-84.95%14K	--0	----	----	-85.59%292K	-60.43%93K
Cash from discontinued financing activities
Financing cash flow	--0	----	----	174.40%19.8M	-84.95%14K	--0	----	----	-87.80%7.21M	-98.10%93K
Net cash flow
Beginning cash position	-56.09%19.73M	-51.98%19.08M	-54.97%17.4M	-67.19%38.64M	-32.07%32.89M	-17.18%44.94M	-52.54%39.74M	-67.19%38.64M	67.19%117.76M	-61.28%48.42M
Current changes in cash	102.46%288K	-86.04%696K	120.95%2M	70.22%-22.02M	-38.12%-16.21M	-286.88%-11.71M	119.05%4.98M	102.75%907K	-246.39%-73.95M	-83.76%-11.73M
Effect of exchange rate changes	-94.66%-656K	-123.11%-49K	-258.00%-316K	115.13%783K	-63.60%708K	88.00%-337K	106.39%212K	120.12%200K	-62.23%-5.18M	315.39%1.95M
End cash Position	-41.14%19.36M	-56.09%19.73M	-51.98%19.08M	-54.97%17.4M	-54.97%17.4M	-32.07%32.89M	-17.18%44.94M	-52.54%39.74M	-67.19%38.64M	-67.19%38.64M
Free cash flow	101.49%146K	89.04%-1.48M	36.65%-7M	11.45%-53.99M	-52.11%-19.66M	-11.12%-9.79M	16.71%-13.5M	52.05%-11.04M	-608.25%-60.97M	-14.50%-12.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data